Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CT-0525 by CTx Operations for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
CT-0525 is under clinical development by CTx Operations and currently in Phase I for Human Epidermal Growth Factor Receptor 2...
CT-0525 by CTx Operations for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
CT-0525 is under clinical development by CTx Operations and currently in Phase I for Gastroesophageal (GE) Junction Carcinomas. According to...
CT-0525 by CTx Operations for Solid Tumor: Likelihood of Approval
CT-0525 is under clinical development by CTx Operations and currently in Phase I for Solid Tumor. According to GlobalData, Phase...